Manhattan Scientifics Reaches the Fork (Falk) in the Road

ALBUQUERQUE, N.M., Aug 19, 2014 (BUSINESS WIRE) Spencer Falk, whose marketing expertise was mission-critical to the blockbuster success of Viagra and Celebrex, among other medical brands, today announced that he would lead the commercialization of early cancer detection technology for Senior Scientific, a division of Manhattan Scientifics (OTCQB:MHTX). Mr. Falk previously held senior marketing positions at Pfizer and Forest Laboratories, and has had a 35-year career in the pharmaceutical and diagnostic sector fields. Gerald Grafe, president of Senior Scientific, commented, We re in the rapid, early-detection business, and the fastest way we know for top corporate partners to detect us is via Mr. Falk s sterling position in the medical device and pharmaceutical industry. Spencer Falk s personal contacts include senior management professionals leading oncology product development at firms including Merck, Astra-Zeneca/Medimmune, Pfizer, Esai, Johnson & Johnson and others. Mr. Falk will
http://bit.ly/VCPxw1